Development of the research and development department at Biofarm sp. z o.o. by purchasing equipment for research purposes (Q80326)

From EU Knowledge Graph
Revision as of 04:17, 29 October 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q80326 in Poland
Language Label Description Also known as
English
Development of the research and development department at Biofarm sp. z o.o. by purchasing equipment for research purposes
Project Q80326 in Poland

    Statements

    0 references
    799,125.0 zloty
    0 references
    191,790.0 Euro
    13 January 2020
    0 references
    3,196,500.0 zloty
    0 references
    767,160.0 Euro
    13 January 2020
    0 references
    25.0 percent
    0 references
    1 May 2019
    0 references
    31 December 2020
    0 references
    BIOFARM SP. Z O.O.
    0 references
    0 references

    52°24'2.2"N, 16°55'11.3"E
    0 references
    Celem projektu jest rozwój istniejącego w firmie Biofarm Działu badawczo-rozwojowego, przez zakup nowej aparatury i sprzętu, która służyć będzie prowadzeniu prac badawczo-rozwojowych na rzecz tworzenia innowacyjnych produktów leczniczych. Realizacja przyczyni się do wzmocnienie potencjału firmy Biofarm do prowadzenia działalności B+R, co jest zgodne z celem i kierunkiem rozwoju firmy, jakim jest stałe rozszerzanie oferty o coraz lepsze, innowacyjne produkty. Wymaga to stałego rozwijania prac badawczych i technologicznych, wdrażania nowych i udoskonalania stosowanych technologii, co pozwoli wytwarzać nowoczesne i bezpieczne dla pacjentów produkty lecznicze zgodnie ze standardami farmaceutycznymi. (Polish)
    0 references
    The aim of the project is to develop the existing R & D Department at Biofarm by purchasing new equipment and equipment to carry out research and development work for the development of innovative medicinal products. The implementation will contribute to strengthening Biofarm’s R & D potential, which is consistent with the company’s goal and direction of development, which is to constantly expand its offer with ever better, innovative products. This requires the continuous development of research and technology, the implementation of new technologies and the improvement of the technologies used to produce modern and safe medicinal products in accordance with pharmaceutical standards. (English)
    14 October 2020
    0 references

    Identifiers

    POIR.02.01.00-00-0005/19
    0 references